CHEMELLO, LILIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.705
AS - Asia 2.329
EU - Europa 1.756
SA - Sud America 51
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
Totale 15.867
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.693
SG - Singapore 1.179
CN - Cina 946
FI - Finlandia 447
DE - Germania 378
IT - Italia 233
SE - Svezia 178
FR - Francia 125
UA - Ucraina 122
RU - Federazione Russa 108
HK - Hong Kong 99
GB - Regno Unito 69
VN - Vietnam 65
BR - Brasile 45
IE - Irlanda 42
NL - Olanda 22
IN - India 17
AT - Austria 13
CI - Costa d'Avorio 12
CA - Canada 8
EU - Europa 5
JP - Giappone 5
TR - Turchia 4
MA - Marocco 3
RO - Romania 3
AU - Australia 2
BG - Bulgaria 2
BZ - Belize 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
ES - Italia 2
IQ - Iraq 2
LK - Sri Lanka 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
PY - Paraguay 2
SI - Slovenia 2
TW - Taiwan 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
CL - Cile 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
HR - Croazia 1
IL - Israele 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
MX - Messico 1
OM - Oman 1
PH - Filippine 1
PK - Pakistan 1
RS - Serbia 1
TM - Turkmenistan 1
TN - Tunisia 1
UY - Uruguay 1
VE - Venezuela 1
Totale 15.867
Salva come PNG Salva come JPEG
Città #
Fairfield 1.644
Jacksonville 1.248
Woodbridge 949
Houston 860
Chandler 819
Wilmington 774
Ashburn 682
Cambridge 601
Seattle 536
Singapore 491
Ann Arbor 473
Princeton 413
Boardman 390
Medford 230
San Diego 207
Nanjing 191
Santa Clara 185
Helsinki 158
Beijing 153
Roxbury 119
Hong Kong 99
Guangzhou 75
Des Moines 74
Shenyang 65
Dong Ket 64
Hebei 60
Nanchang 59
Jiaxing 54
Padova 52
Changsha 49
New York 45
Norwalk 45
Dublin 42
Tianjin 35
Jinan 30
Nuremberg 27
Dearborn 24
Redwood City 23
Hefei 22
Kharkiv 19
Kunming 16
Zhengzhou 15
London 14
Borås 13
Milan 13
Ogden 13
Abidjan 12
Dallas 11
Pune 9
Ningbo 8
Selvazzano Dentro 8
Wuhan 8
Auburn Hills 7
Venice 7
Vienna 7
Falkenstein 6
Rockville 6
Rome 6
San Jose 6
Chiswick 5
Hirakata 5
Indiana 5
Los Angeles 5
Buffalo 4
Kilburn 4
Villafranca Padovana 4
Washington 4
Bari 3
Bologna 3
Chicago 3
Detroit 3
Eboli 3
Fabriano 3
Ferentino 3
Fremont 3
Fuzhou 3
Hangzhou 3
Hanover 3
Legnaro 3
Orange 3
Taizhou 3
Yenibosna 3
Acton 2
Agordo 2
Asunción 2
Belize City 2
Casablanca 2
Chongqing 2
Colombo 2
Cosenza 2
Goiânia 2
Gualdo Tadino 2
Harbin 2
Horia 2
Kanniyākumāri 2
Lappeenranta 2
Leeds 2
Majadahonda 2
Mestre 2
New Bedfont 2
Totale 12.388
Salva come PNG Salva come JPEG
Nome #
Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. 152
Focal nodular hyperplasia of the liver: an emerging complication of hematopoietic SCT in children. 144
Newly diagnosed Hepatocellular Carcinoma in patients with advanced hepatitis C treated with DAAs: a prospective population study 144
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 140
Liver stellate cells in chronic viral hepatitis : the effect of interferon therapy. 125
ANTIBODY TO THE POLYALBUMIN (pHSA) RECEPTOR ON HEPATITIS B VIRUS IN ACUTE INFECTION AND IN VACCINE RECIPIENTS 123
Peripheral neurotoxicity of pegylated interferon alpha: a prospective study in patients with HCV. 119
Kinetic of virological response during PEG-IFNs in chronic hepatitis C. 116
SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection 116
Modeling cost-effectiveness and health gains of a "universal" versus "prioritized" hepatitis C virus treatment policy in a real-life cohort 111
Progressive increase of SCCA-IgM immune complexes in cirrhotic patients is associated with development of hepatocellular carcinoma 110
SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection 110
Hepatitis C virus reinfection in liver transplant patients: evaluation of liver damage progression with echo-color doppler. 107
Performance and utility of transient elastography and noninvasive markers of liver fibrosis in primary biliary cirrhosis. 106
Acute hepatitis C virus infection in a nurse trainee following a needlestick injury 105
Cognitive effects of long-term interferon treatment for chronic viral hepatitis 104
Squamous cell carcinoma antigen-1 (SERPINB3) polymorphism in chronic liver disease 104
Hepatitis C Virus Reinfection in Liver Transplant Patients: Evaluation of Liver Damage Progression with Echo-Color Doppler 104
Squamous cell carcinoma antigen (SCCA) expression and CD27+ memory B lymphocytes in patients with chronic hepatitis C 103
HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND HEPATITIS-C PATHOLOGY 101
Liver cell apoptosis in chronic hepatitis C correlates with histological but not biochemical activity or serum HCV-RNA levels 100
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: An individual patient data meta-analysis 100
HEART RATE VARIABILITY PARALLELS CHANGES IN PSYCHIATRIC SCALES IN INTERFERON-TREATED PATIENTS WITH CHRONIC HEPATITIS 98
Cognitive effects of long-term interferon treatment for chronic viral hepatitis 97
Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis C. 96
Profiles of HCV core protein and viremia in chronic hepatitis C: Possible protective role of core antigen in liver damage 96
Efficacy of a second cycle of interferon therapy in patients with chronic hepatitis C. 95
A model to predict long-term sustained response to interferon therapy in chronic hepatitis C 94
PERFORMANCE OF TRANSIENT ELASTOGRAPHY AND NON INVASIVE MARKERS OF LIVER FIBROSIS IN PRIMARY BILIARY CIRRHOSIS 94
Prevalence and characteristics of peripheral neuropathy in hepatitis C virus population 92
Natural history of hepatitis C. 92
A COST-EFFECTIVENESS ANALYSIS OF PROPHYLAXIS OF VARICEAL BLEEDING STARTING FROM SMALL ESOPHAGEAL VARICES COMPARED TO SURVEILLANCE AND TREATMENT STARTING FROM LARGE ONES 91
Mood, cognition and EEG changes during interferon alpha (alpha-IFN) treatment for chronic hepatitis C. 91
PERFORMANCE OF TRANSIENT ELASTOGRAPHY AND NON INVASIVE MARKERS OF LIVER FIBROSIS IN PRIMARY BILIARY CIRRHOSIS 90
Therapy of hepatitis C: re-treatment with alpha interferon. 88
Characteristics of hepatitis C virus before and after interferon treatment in patients with ongoing viraemia but sustained biochemical response. 88
HEPATITIS C VIRUS SEROTYPES AND LIVER PATHOLOGY 88
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: the International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program. 88
Effects of PEG-interferon alpha plus ribavirin on tryptophan metabolism in patients with chronic hepatitis C 88
Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma. 88
Advanced liver disease outcomes after hepatitis C eradication by human immunodeficiency virus infection in PITER cohort 86
OUTCOME OF ACUTE HEPATITIS C AND ROLE OF ALPHA INTERFERON THERAPY 83
Serum markers of hepatic fibrogenesis in chronic hepatitis type C treated with alfa‐2A interferon 81
Monitoring SCCA-IgM complexes in serum predicts liver disease progression in patients with chronic hepatitis 81
NATURAL KILLER ACTIVITY IN PATIENTS WITH ACUTE VIRAL HEPATITIS 80
Changes in serum hepatitis B virus (HBV) DNA positivity in chronic HBV infection: results of a long-term follow-up study of 138 patients. 80
Anti-interferon antibodies during interferon therapy for chronic hepatitis C. 79
Latent hepatitis B virus infection in childhood hepatocellular carcinoma. Analysis by polymerase chain reaction. 79
Alterazioni neurovascolari nell’epatite cronica C: uno studio caso-controllo 78
Liver Angiopoietin-2 Is a Key Predictor of De Novo or Recurrent Hepatocellular Cancer After Hepatitis C Virus Direct-Acting Antivirals 77
Interferon-ribavirin combination therapy for chronic hepatitis C. 76
PREDICTIVE MARKERS OF CHRONICITY IN ACUTE HEPATITIS TYPE B 76
RELATIONSHIP BETWEEN HBcAg IN SERUM AND LIVER AND HBV REPLICATION IN PATIENTS WITH HBsAg POSITIVE CHRONIC LIVER DISEASE 76
Monitoring SCCA-IgM complex predicts hcc development in cirrhotic patients 75
HEPATITIS C VIRAEMIA AND LIVER DISEASE IN SYMPTOM-FREE INDIVIDUALS WITH ANTI-HCV 75
A cost-effectiveness analysis of prophylaxis of variceal bleeding starting from small esophageal varices compared to surveillance and treatment starting from large ones. 75
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 75
HEPATITIS C VIRUS RNA PROFILES IN CHRONICALLY INFECTED INDIVIDUALS: DO THEY RELATE TO DISEASE ACTIVITY? 74
Human leucocyte interferon-alpha in the treatment of chronic hepatitis C 74
Monoclonal radioimmunoassay for hepatitis B surface antigen in sera of children with acute leukemia. 74
Validation of a new sonographic parameter (liver/kidney ratio of greys intensity of digital images) for diagnosis and quantification of liver steatosis 73
Hepatitis B core antigen (HBcAg) in serum of patients with chronic hepatitis B detected by a modified radioimmunoassay. 73
Relapse after direct-acting antivirals (DAAs) in cirrhotic patients with hepatitis C is highly related to development of liver cancer 73
Prognostic value of liver and spleen stiffness in patients with fontan associated liver disease (Fald): A case series with histopathologic comparison 73
Neurotoxychological Monitoring of Interferon treatment in Viral Hepatitis: a Pilot Sudy 72
Virus receptors for polymerized human serum albumin and anti-receptor antibody in hepatitis B virus infection. 72
SERUM HBV-DNA IN ANTI-HBE POSITIVE PATIENTS DETECTED BY FILTER AND LIQUID-PHASE HYBRIDIZATION ASSAYS 71
Epidemiological, clinical and therapeutic associations of hepatitis C types in western European patients. 71
Heart rate variability parallels changes in psychiatric scales in interferon-treated patients with chronic hepatitis. 70
Chronic evolution of acute hepatitis type B: prevalence and predictive markers 70
ALTERAZIONI DELL'ATTIVITA' NATURAL KILLER IN CORSO DI INFEZIONE DA VIRUS EPATITICI 70
The cognitive effects of long-term interferon treatment for chronic viral hepatitis 70
EVIDENCE OF HEPATITIS B VIRUS INFECTION IN CHRONIC HEPATITIS HBsAg NEGATIVE BY CONVENTIONAL ASSAYS 70
Hepatitis C serotype and response to interferon therapy. 70
IFN treatment in viral Hepatitis really affect mood and cognition? Neuropsychological Changes and Electrophysiological correlates 69
Espressione della serpina SCCA in cellule mononucleate di sangue periferico in pazienti con infezione cronica da HCV 69
Retrospective analysis of the effect of interferon therapy on the clinical outcome of patients with viral cirrhosis. 69
ANTIGENE CORE NEL SIERO .DETERMINAZIONE E SIGNIFICATO IN PAZIENTI CON INFEZIONE ACUTA E CRONICA DA VIRUS DELL'EPATITE B 69
Epidemiological and clinical profile of HCV Chronic carriers in the area of northern Italy 68
FINE SPECIFICITY OF HUMAN ANTIBODY RESPONSE TO THE PRE S1 DOMAIN OF HEPATITIS B VIRUS 68
BIOLOGIA MOLECOLARE APPLICATA AL VIRUS DELL'EPATITE B. STUDIO DEL DNA VIRALE NEL SIERO E NEL FEGATO E CORRELAZIONE CLINICA 68
CHRONIC HEPATITIS C: INTERFERON RETREATMENT OF RELAPSERS. A META-ANALYSIS OF INDIVIDUAL PATIENTS DATA. EUROPEAN CONCERTED ACTION ON VIRAL HEPATITIS (EUROHEP) 67
COMPARISON OF DIFFERENT TYPES AND DOSES OF ALPHA IFN FOR TREATMENT OF CHRONIC HEPATITIS C 67
COMPARISON OF GENOTYPING AND SEROTYPING METHODS FOR THE IDENTIFICATION OF HEPATITIS C VIRUS TYPES 67
RESPONSE TO RIBAVIRIN, TO INTERFERON AND TO A COMBINATION OF BOTH IN PATIENTS WITH CHRONIC HEPATITIS C AND ITS RELATION TO HCV GENOTYPES 66
Serum hepatitis B virus DNA in acute hepatitis type B 66
DEREGOLAZIONE DELL’ESPRESSIONE DI SCCA (SQUAMOUS CELL CARCINOMA ANTIGEN) NEI LINFOCITI B IN PAZIENTI INFETTI DA HCV 66
ESPRESSIONE DELLA SERPINA SCCA IN CELLULE MONONUCLEATE DI SANGUE PERIFERICO IN PAZIENTI CO INFEZIONE CRONICA DA HCV 66
A MODEL TO PREDICT SUSTAINED RESPONSE TO THERAPY AND TO OPTIMIZE THE DOSE OF INTERFERON IN CHRONIC HEPATITIS C 66
Real-life use of elbasvir/grazoprevir in adults and elderly patients: a prospective evaluation of comedications used in the PITER cohort 66
Patterns of antibodies to hepatitis C virus in patients with chronic non-A, non-B hepatitis and their relationship to viral replication and liver disease. 65
CLINICAL FEATURES AND RESPONSE TO INTERFERON IN PATIENTS WITH DIFFERENT HCV GENOTYPES IN ITALY 65
CHRONIC HEPATITIS C WITHOUT ANTIBODY TO C-100 65
Chonic hepatitis C: interferon retreatment of relapsers. A meta-analysis of individual patient data. 64
Antibody to hepatitis C virus and liver disease in volunteer blood donors. 64
TIMING AND DOSE EFFECT OF ALPHA-INTERFERON ON EARLY VIRAL KINETICS IN CHRONIC HEPATITIS C 63
Deregulation of Squamous Cell Carcinoma Antigen (SCCA) expression in B lymphocytes in patients with chronic hepatitis C 63
Serum and liver HCV RNA levels in patients with chronic hepatitis C: correlation with clinical and histological features. 63
Antibody response to pre-S2 and hepatitis B virus induced liver damage. 63
COMPARISON OF THRICE WEEKLY VS DAILY HUMAN LEUCOCYTE INTERFERON-ALPHA THERAPY FOR CHRONIC HEPATITIS C. TVVH STUDY GROUP. 62
Totale 8.464
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.827
article - articoli 48.957
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 521
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.949
Totale 115.254
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.035 0 0 0 0 0 0 0 0 264 410 128 233
2020/20211.877 99 217 67 112 49 257 37 150 332 154 176 227
2021/20222.689 42 483 200 243 79 150 112 264 139 52 306 619
2022/20231.979 602 160 62 146 315 235 8 115 196 23 100 17
2023/2024818 38 102 81 51 36 74 48 29 21 22 125 191
2024/20252.498 4 308 197 135 716 76 182 324 556 0 0 0
Totale 15.943